Highlights Hologic, Inc.

Equities

HOLX

US4364401012

Market Closed - Nasdaq Other stock markets 21:00:00 09/09/2024 BST			5-day change	1st Jan Change
82.69 ^USD	+1.37%		+1.78%	+15.73%

09-05	Transcript : Hologic, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 12:20 PM
08-02	Stephens Raises Hologic's Price Target to $95 From $92	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Global markets live: Diageo, Apple, Tesla, Meta Platforms, PayPal, Pfizer...	07-30
Hologic quarterly profit rises on strong demand for its women's health products	07-29	RE
Hologic Fiscal Q3 Non-GAAP EPS, Revenue Rise; 2024 Outlook Updated	07-29	MT
(HOLX) HOLOGIC Forecasts Fiscal Year 2024 EPS Range $4.04 - $4.11	07-29	MT
Earnings Flash (HOLX) HOLOGIC Posts Q3 Revenue $1.01B, vs. Street Est of $1B	07-29	MT
(HOLX) HOLOGIC Forecasts Q4 EPS Range $0.97 - $1.04	07-29	MT
Earnings Flash (HOLX) HOLOGIC Posts Q3 EPS $1.06, vs. Street Est of $1.01	07-29	MT
Tranche Update on Hologic, Inc.'s Equity Buyback Plan announced on September 23, 2022.	07-29	CI
Hologic, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024	07-29	CI
Hologic, Inc. Revises Earnings Guidance for the Full Year 2024	07-29	CI
Hologic, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 29, 2024	07-29	CI
Global markets live: Apple, 3M Company, Boeing, Honeywell...	07-29
Molten Ventures Finalizes Exit from Endomagnetics	07-26	MT
Hologic Completes Endomagnetics Acquisition for $310 Million	07-25	MT
Hologic, Inc. completed the acquisition of Endomagnetics Ltd. for approximately $310 million.	07-24	CI
Lumos Diagnostics Receives $400,000 in Milestone Payment from Hologic; Shares Up 3%	06-19	MT
FDA classifies recall of Hologic's implant as 'most serious'	05-22	RE
FDA classifies recall of Hologic's implants for soft tissue as 'most serious'	05-22	RE
Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	05-06	MT
Tranche Update on Hologic, Inc.'s Equity Buyback Plan announced on November 9, 2023.	05-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

From Mammograms to Molecules: Hologic's Quest in Women's Health Tech

July 31, 2024 at 06:23 pm